Adverse Events in Infants Following BCG Vaccination ver 1.0

  • Research type

    Research Study

  • Full title

    Adverse Events in Infants Following Bacillus Calmette-Guérin Vaccination

  • IRAS ID

    186402

  • Contact name

    Elizabeth Whittaker

  • Contact email

    elizabeth.whittaker2@nhs.net

  • Sponsor organisation

    Imperial College, London

  • Duration of Study in the UK

    2 years, 5 months, 18 days

  • Research summary

    Newborn infants in the UK who are at high risk of tuberculosis exposure receive Bacillus Calmette-Guérin (BCG) vaccination at birth. A small but significant proportion of BGC-vaccinated infants develop vaccine-related adverse events; the current literature reports wide-ranging estimates for their incidence.

    We now know that almost all children who develop severe disseminated BCG disease have an underlying immunodeficiency. However, it remains unclear if infants who develop less severe complications possess more subtle defects of the immune system.

    We aim to describe the incidence of adverse events in infants following BCG vaccination. We also plan to improve our understanding of the immune response to BCG in young infants with immature immune systems via laboratory testing of blood samples for RNA expression.

    We will work in close collaboration with the Northwest London Clinical Research Network (NWLCRN) and will work in a number of selected GP practices in Northwest London. Over a 12 month period, all BCG-vaccinated children receiving their routine 2, 3 and 4 month vaccinations will be evaluated for the presence of axillary lymphadenopathy. If lymphadenopathy is present they will be invited to join the study. Children with any BCG-related adverse event will also be recorded.

    We expect this study to enhance our knowledge of the immature immune system in young infants and specifically its response to BCG vaccine. We also anticipate an improved understanding of the frequency of adverse events following BCG vaccination.

  • REC name

    London - London Bridge Research Ethics Committee

  • REC reference

    17/LO/0311

  • Date of REC Opinion

    16 May 2017

  • REC opinion

    Further Information Favourable Opinion